Rx DRUG PRICE ADVISORY COUNCIL MAY ALSO WEIGH REVIEW OF OTCs
This article was originally published in The Tan Sheet
Rx DRUG PRICE ADVISORY COUNCIL MAY ALSO WEIGH REVIEW OF OTCs under legislation adopted by the House Education & Labor Committee June 15. The legislation, an amendment to President Clinton's Health Security Act (HR 3600) offered by Rep. George Miller (D- Calif.), would add the possibility of federal price reviews for OTC drugs to Clinton's health reform bill. The amendment was adopted by the panel in a 26-16 vote.
You may also be interested in...
Perrigo promotes in pricing, planning
Combe sells most of its OTC brands
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC